Science Abstracts
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
May 2012
May 2012
Authors : Marianna Mazza1 , Maria Rosaria Squillacioti1 , Riccardo Daniele Pecora2 , Luigi Janiri1 , Pietro Bria1
Affliation :
1Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy ; ; ; mariannamazza@hotmail.com
2Polo Ospedaliero SS. Trinità, Sora, ASL Frosinone, Italy
DOI : 10.1517/14656560802504490
Published in : Expert Opin. Pharmacother.
Subject: Original research
Keywords: aripiprazole , bipolar disorder , depression , open label
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- European generics firms, squeezed between innovators and payers, seek diversity
- Takeda resubmits alogliptin NDAs in US as cardiovascular data become available
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- UK govt offers "step change" in support for regenerative medicine
